Skip to main content
. 2020 Sep 7;2020:8345235. doi: 10.1155/2020/8345235

Figure 2.

Figure 2

Patients exhibiting a CR of multiple lung metastases and liver metastases after TILs plus anti-PD1 therapy. (a) The patient achieved a CR of multiple lung metastases (the yellow arrows) after 3 months of immunotherapy. (b) The patient achieved a CR of multiple liver metastases (the yellow arrows) after 4 months of immunotherapy.